N. Fantò

Pharmacological inhibition of TLR9 activation blocks autoantibody production in human B cells from SLE patients.

C. Sette, V. Ruggiero, R. De Santis, 2010, Rheumatology.

Design, synthesis, and in vitro activity of peptidomimetic inhibitors of myeloid differentiation factor 88.

V. Ruggiero, R. De Santis, G. Basile, 2008, Journal of medicinal chemistry.

New benzofuran-imidazoles as antimycotic agents. I. Synthesis and characterization.

D. Giannotti, A. Giolitti, V. Pestellini, 1987, Chemioterapia : international journal of the Mediterranean Society of Chemotherapy.

New benzofuran-imidazoles as antimycotic agents. II. In vitro studies.

D. Giannotti, A. Giolitti, V. Pestellini, 1987, Chemioterapia : international journal of the Mediterranean Society of Chemotherapy.

Pivotal Advance: Inhibition of MyD88 dimerization and recruitment of IRAK1 and IRAK4 by a novel peptidomimetic compound

Grazia Gallo, Vito Ruggiero, Paolo Carminati, 2007, Journal of leukocyte biology.

Identification of Critical Residues of the MyD88 Death Domain Involved in the Recruitment of Downstream Kinases*

C. Sette, V. Ruggiero, R. De Santis, 2009, Journal of Biological Chemistry.

ST7612AA1, a thioacetate-ω(γ-lactam carboxamide) derivative selected from a novel generation of oral HDAC inhibitors.

G. Giannini, M. Mor, C. Pisano, 2014, Journal of medicinal chemistry.

Peptide-mediated Interference of TIR Domain Dimerization in MyD88 Inhibits Interleukin-1-dependent Activation of NF-κB*

C. Sette, V. Ruggiero, P. Carminati, 2005, Journal of Biological Chemistry.

ST7612AA1, a thioacetate-ω(γ-lactam carboxamide) derivative selected from a novel generation of oral HDAC inhibitors.

G. Giannini, M. Mor, C. Pisano, 2014, Journal of medicinal chemistry.

Pharmacological inhibition of TLR9 activation blocks autoantibody production in human B cells from SLE patients.

C. Sette, V. Ruggiero, R. De Santis, 2010, Rheumatology.